Time-Varying Heterogeneous Treatment Effects in Event Studies
事件研究中的时变异质性处理效应AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要明确研究事件研究处理效应,并采用短期动态面板与相关随机系数模型。
事件研究中的时变异质性处理效应AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
This paper examines the identification and estimation of heterogeneous treatment effects in event studies, emphasizing the importance of both lagged dependent variables and treatment effect heterogeneity. We show that omitting lagged dependent variables can induce omitted variable bias in the estimated time-varying treatment effects. We develop a novel semiparametric approach based on a short-T dynamic linear panel model with correlated random coefficients, where the time-varying heterogeneous treatment effects can be modeled by a time-series process to reduce dimensionality. We construct a two-step estimator employing quasi-maximum likelihood for common parameters and empirical Bayes for the heterogeneous treatment effects. The procedure is flexible, easy to implement, and achieves ratio optimality asymptotically. Our results also provide insights into common assumptions in the event study literature, such as no anticipation, homogeneous treatment effects across treatment timing cohorts, and state dependence structure.
高效的双重差分与事件研究估计量
This paper investigates efficient Difference-in-Differences (DiD) and Event Study (ES) estimation using short panel data sets within the heterogeneous treatment effect framework, free from parametric functional form assumptions and allowing for variation in treatment timing. We provide an equivalent characterization of the DiD potential outcome model using sequential conditional moment restrictions on observables, which shows that the DiD identification assumptions typically…
LongBet:面板数据中的异质性处理效应估计
This paper introduces a novel approach for estimating heterogeneous treatment effects of binary treatment in panel data, particularly focusing on short panel data with large cross-sectional data and observed confoundings. In contrast to traditional literature in difference-in-differences method that often relies on the parallel trend assumption, our proposed model does not necessitate such an assumption. Instead, it leverages observed confoundings to impute potential…
去偏且具有半参数效率的变化中变化估计量
We present a novel extension of the influential changes-in-changes (CiC) framework of Athey and Imbens (2006) for estimating the average treatment effect on the treated (ATT) and distributional causal effects in panel data with unmeasured confounding. While CiC relaxes the parallel trends assumption in difference-in-differences (DiD), existing methods typically assume a scalar unobserved confounder and monotonic outcome relationships, and lack inference tools that…
利用双重差分与机器学习高效估计纵向处理效应
Difference-in-differences is based on a parallel trends assumption, which states that changes over time in average potential outcomes are independent of treatment assignment, possibly conditional on covariates. With time-varying treatments, parallel trends assumptions can identify many types of parameters, but most work has focused on group-time average treatment effects and similar parameters conditional on the treatment trajectory. This paper focuses instead on…
用于双重差分的森林:超越参数模型的因果推断
This paper introduces the Difference-in-Differences Bayesian Causal Forest (DiD-BCF), a novel non-parametric model addressing key challenges in DiD estimation, such as staggered adoption and heterogeneous treatment effects. DiD-BCF provides a unified framework for estimating Average (ATE), Group-Average (GATE), and Conditional Average Treatment Effects (CATE). A core innovation, its Parallel Trends Assumption (PTA)-based reparameterization, enhances estimation accuracy and…
估计纵向替代结局治疗效应的半参数联合模型:慢性肾病试验应用
In clinical trials where long follow-up is required to measure the primary outcome of interest, there is substantial interest in using an accepted surrogate outcome that can be measured earlier in time or with less cost to estimate a treatment effect. For example, in clinical trials of chronic kidney disease (CKD), the effect of a treatment is often demonstrated on a surrogate outcome, the longitudinal trajectory of glomerular filtration rate (GFR). However, estimating the…